TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Immunovia AB
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
1,058
|
765
|
614 |
| Financial expenses |
12,934
|
12,163
|
2,761 |
| Earnings before taxes |
-207,842
|
-112,325
|
-113,408 |
| EBITDA |
-103,936
|
-111,085
|
-107,299 |
| Total assets |
66,282
|
200,864
|
359,064 |
| Current assets |
54,077
|
77,258
|
216,032 |
| Current liabilities |
20,085
|
16,095
|
23,814 |
| Equity capital |
44,996
|
162,917
|
315,504 |
| - share capital |
1,521
|
756
|
823 |
| Employees (average) |
36
|
64
|
66 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
67.9%
|
81.1%
|
87.9% |
| Turnover per employee |
29
|
12
|
9 |
| Profit as a percentage of turnover |
-19644.8%
|
-14683.0%
|
-18470.4% |
| Return on assets (ROA) |
-294.1%
|
-49.9%
|
-30.8% |
| Current ratio |
269.2%
|
480.0%
|
907.2% |
| Return on equity (ROE) |
-461.9%
|
-68.9%
|
-35.9% |
| Change turnover |
289
|
201
|
350 |
| Change turnover % |
38%
|
36%
|
133% |
| Chg. No. of employees |
-28
|
-2
|
3 |
| Chg. No. of employees % |
-44%
|
-3%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.